In contrast, LIN28B has been shown to be overexpressed in high-risk neuroblastoma, leading to increased MYCN expression and stabilization by both inhibiting the miRNA let-7, and increasing RAN and AURKA expression [104,105]. Here, MYCN is linked to neuroblastoma.